rhTNF-α
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rhTNF-α, covering 2015-06-16 to 2015-06-16. Get the full timeline:
Most recent: Clinical Trial Update: Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas [Phase 1]